Company intelligence / Profile preview

Mikart

Atlanta, Georgia, United States

Ownership: Private
Employees: ~183
Development stage: Other

Overview

Mikart is a CDMO with over 50 years of expertise, focusing on formulation, GMP manufacturing, packaging, and regulatory support for oral solid and non-sterile liquid dosage pharmaceutical products. No proprietary clinical results, as Mikart does not have a self-owned pipeline.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Nano PharmaSolutions (NanoTransformer™ nanosizing technology)Fluid Pharma (MicroCoat™ drug delivery technology)

Beyond the preview

Go deeper on Mikart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mikart.

Explore the full profile